The House passes pro-investment legislation backed by BIO. Plus, Bayh-Dole turns 45. (861 words, 4 minutes, 18 seconds) House passes INVEST Act, BIO-backed legislation to increase access to capital ...
The contents of the member listings on the BIO Web site may not be reproduced or used in any form without prior written permission from BIO. For more information about members, please refer to the ...
BIO is proud to welcome the following innovators to our membership in 2025. Your leadership and engagement strengthens our collective ability to advance policy, drive innovation, and support the next ...
Every year, JPM Healthcare Week sets the pace for biotech deal-making. But the skills and insights you gain from preparing for high stakes partnering meetings are valuable long after January. In this ...
The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace ...
Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic ...
“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the ...
The United States International Trade Commission (USITC) today released its “COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities” report. The report aims to ...
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities. "Manufacturers should have the choice to effectuate ...
The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States. The new report, The U.S ...
Washington, D.C. (May 25, 2016) – Today, the Biotechnology Innovation Organization (BIO) released the largest ever study of clinical development success rates. The study, conducted in partnership with ...
The Biotechnology Innovation Organization (BIO) today released a new report examining antibacterial innovation and the current pipeline for new antibacterial medicines, The State of Innovation in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback